Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.43 | N/A | -1.45% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.43 | N/A | -1.45% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about current market conditions impacting performance. They reiterated their commitment to strategic initiatives for future growth.
Management noted challenges in achieving profitability this quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
The earnings report indicates that Teladoc Health is still facing challenges, particularly in achieving profitability. The stock fell 3.9% in reaction to the missed EPS expectations, reflecting investor concerns about the company's short-term performance and market conditions. Without guidance, uncertainty remains about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SOUTHERN COPPER CORP
Apr 29, 2019